BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3031335)

  • 1. Autologous bone marrow transplantation in acute lymphoblastic leukemia following in vitro treatment with monoclonal antibodies and with complement: analyses for two cases of failure.
    Ito T; Ishikawa Y; Noda M; Fujii R
    Jpn J Clin Oncol; 1987 Mar; 17(1):63-9. PubMed ID: 3031335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
    Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
    Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
    Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J
    Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
    Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
    Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia.
    Bai Y; Piao XH; Luo QL; Mao BZ
    Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
    Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K
    Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement.
    Ramsay N; LeBien T; Nesbit M; McGlave P; Weisdorf D; Kenyon P; Hurd D; Goldman A; Kim T; Kersey J
    Blood; 1985 Sep; 66(3):508-13. PubMed ID: 3896344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
    Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
    Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children.
    Hoogerbrugge PM; Gerritsen EJ; vd Does-van den Berg A; vd Berg H; Zwinderman AH; Hermans J; Vossen JM
    Bone Marrow Transplant; 1995 Feb; 15(2):255-9. PubMed ID: 7773215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of bone marrow transplantation to the treatment of children with leukemia].
    Vossen JM; van Leeuwen EF; van 't Veer-Korthof ET; Slaper-Cortenbach CM; van den Berg H; Gerritsen EJ; Hermans J; Weening RS
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):73-82. PubMed ID: 3287686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogeneic bone marrow transplantation in acute lymphoblastic leukemia of children. Analysis of prognostic factors. GEGMO (Bone Marrow Study Group) study].
    Bordigoni P; Vernant JP; Souillet G; Philippe N; Maraninchi D
    Arch Fr Pediatr; 1986 Dec; 43(10):765-8. PubMed ID: 3548632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytomegaloviral interstitial pneumonia after autologous bone marrow transplantation in a case of acute lymphoblastic leukemia. Bone Marrow Transplantation Team].
    Koyama T; Noguchi M; Maruyama Y; Akiyama H; Sakamaki H; Onozawa Y; Takizawa T; Koike M
    Rinsho Ketsueki; 1992 Jan; 33(1):69-74. PubMed ID: 1312180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
    Pinkerton CR; Chessells JM
    Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation.
    Donadieu J; Stephan JL; Blanche S; Cavazzana-Calvo M; Baruchel A; Herbelin C; Benkerrou M; Thomas C; Girault D; Fischer A
    Bone Marrow Transplant; 1994 Jun; 13(6):777-82. PubMed ID: 7920314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autologous bone marrow transplantation in children with acute leukemia].
    Matsuyama T; Kojima S; Miyajima Y; Fukuda M
    Rinsho Ketsueki; 1990 Oct; 31(10):1626-32. PubMed ID: 2255054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.